Status:
RECRUITING
D20054;LITT for Spine Tumors
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Spinal Metastases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates ...
Eligibility Criteria
Inclusion
- Histology confirmed spinal tumor involving the T2-T12 spine segments.
- Indication for spine stereotactic radiosurgery or palliative intervention.
- Normal neurologic exam at the time of presentation (Frankel grade E).
Exclusion
- Contraindication to MRI
- ANY neurologic deficit
- Tumor spanning more than 3 consecutive vertebral segments
- Contraindication to general anesthesia
- Pregnancy
Key Trial Info
Start Date :
May 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06548061
Start Date
May 16 2024
End Date
June 1 2029
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth Health
Lebanon, New Hampshire, United States, 03766